Deal Library / Pharma BD Deal Intelligence

Hospira, Inc. — Pharma Deals

The Pharma Closeout tracks 3 deals, $945M in disclosed deal value, 3 with a post-close Outcome Score for Hospira, Inc..

Median Critic Score: 88  ·  Median Outcome Score: 23

Best outcome: Hospira, Inc. / Javelin Pharmaceuticals, Inc. (25)  ·  Weakest outcome: Hospira, Inc. / Orchid Chemicals & Pharmaceuticals Ltd. (Generic Injectables business) (22)

All 3 deals

• Hospira, Inc. / Javelin Pharmaceuticals, Inc. — 2010 · $145M · Did not work — the deal failed to deliver.
• Hospira, Inc. / Orchid Chemicals & Pharmaceuticals (Generic Injectables Business) — 2010 · $400M · Did not work — the deal failed to deliver.
• Hospira, Inc. / Orchid Chemicals & Pharmaceuticals Ltd. (Generic Injectables business) — 2009 · $400M · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals